Recomienda este artículo a tus amigos:
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy Elisabeth Bergen 2011 edition
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy
Elisabeth Bergen
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.
110 pages, biography
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 25 de febrero de 2013 |
| ISBN13 | 9783034803182 |
| Editores | Springer Basel |
| Páginas | 110 |
| Dimensiones | 155 × 235 × 7 mm · 181 g |
| Lengua | Alemán |
| Editor | Bartsch, Rupert |
| Editor | Grunt, Thomas W. |
| Editor | Sibilia, Maria |
| Editor | Zielinski, Christoph C. |